← Open Payments lookup

SURESH SUREDDI: Open Payments

NPI 1710932561 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$401,898 in 491 payments from 11 companies in 2025. Trend: 2023 $415,070 · 2024 $369,614 · 2025 $401,898

Speaker / faculty: $227,784Honoraria: $89,779Travel & lodging: $38,391Consulting: $37,325Food & beverage: $8,562Education: $58
CompanyPaymentsAmount
Axsome Therapeutics, Inc.111$105,328
Alkermes, Inc.101$81,552
Otsuka America Pharmaceutical, Inc.70$63,945
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)69$58,937
Neurocrine BioSciences, Inc.45$50,980
Teva Pharmaceuticals USA, Inc.42$34,629
E.R. Squibb & Sons, L.L.C.41$4,510
Otsuka Pharmaceutical Development & Commercialization, Inc.2$1,721
Janssen Pharmaceuticals, Inc5$201
Vanda Pharmaceuticals Inc.3$61

Products named: Auvelity, CAPLYTA, ABILIFY MAINTENA, INGREZZA, LYBALVI, AUSTEDO XR, ARISTADA, ABILIFY ASIMTUFII.

Industry payments across TX — which companies pay providers there.